semaglutide & tirzepatide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity The Difference Between Semaglutide and

GLP-1 helps control appetite, balance blood sugar, reduce cravings, and support fat loss while protecting lean muscle

From picking your plan to getting care, here's how easy it is to get started

Tirzepatide Tirzepatide introduced dual GIP/GLP-1 receptor activation, delivering greater weight loss than earlier GLP-1 therapies and redefining expectations for pharmacologic obesity management

Our team is dedicated to supporting your breakthroughs, providing not just the compounds, but the confidence you need to push the boundaries of biological research

There is thus a clear need for a trial over a longer period looking at these areas

It is important to note that a direct, well-established causal link between GLP-1 receptor agonist use and clinically significant B12 deficiency has not been confirmed in the published literature